Activation of human brown adipose tissue by a β3-adrenergic receptor agonist.

Activation of human brown adipose tissue by a β3-adrenergic receptor agonist.
复制标题

DOI:
10.1016/j.cmet.2014.12.009
复制
发表时间:
2015-01-06
期刊:
影响因子:
29
通讯作者:
Kolodny GM
Kolodny GM
中科院分区:
生物学1区
文献类型:
--
作者:
Cypess AM;Weiner LS;Roberts-Toler C;Franquet Elía E;Kessler SH;Kahn PA;English J;Chatman K;Trauger SA;Doria A;Kolodny GM

文献摘要

参考文献

被引文献

相似文献

通过激活内源性棕色脂肪组织(BAT)增加能量消耗是治疗肥胖和糖尿病的一种潜在方法。这类β3肾上腺素能受体(AR)激动剂可以刺激啮齿动物蝙蝠,但这种活性从未在人类身上得到证实。在这里,我们确定了与安慰剂相比,200毫克口服米拉贝格隆(美贝特,阿斯特拉斯制药公司)刺激BAT的能力。米拉贝格隆是一种目前被批准用于治疗膀胱过度活跃的β3-AR激动剂。在所有12名健康男性受试者中,通过正电子发射断层扫描结合计算机断层扫描的18F-脱氧葡萄糖测定,米拉贝格隆导致BAT代谢活性增加(p=0.001),并使静息代谢率增加203±40千卡/天(+13%;p=0.001)。BAT代谢活动也是RMR变化的重要预测因子(p=0.006)。因此,β-3-AR激动剂可以刺激人BAT的产热,有望成为治疗代谢性疾病的一种有前途的药物。
Increasing energy expenditure through activation of endogenous brown adipose tissue (BAT) is a potential approach to treat obesity and diabetes. The class of β3-adrenergic receptor (AR) agonists stimulates rodent BAT, but this activity has never been demonstrated in humans. Here we determined the ability of 200 mg oral mirabegron (Myrbetriq, Astellas Pharma, Inc.), a β3-AR agonist currently approved to treat overactive bladder, to stimulate BAT as compared to placebo. Mirabegron led to higher BAT metabolic activity as measured via 18F-fluorodeoxyglucose (18F-FDG) using positron emission tomography (PET) combined with computed tomography (CT) in all twelve healthy male subjects (p = 0.001), and it increased resting metabolic rate (RMR) by 203 ± 40 kcal/day (+13%; p = 0.001). BAT metabolic activity was also a significant predictor of the changes in RMR (p = 0.006). Therefore, a β3-AR agonist can stimulate human BAT thermogenesis and may be a promising treatment for metabolic disease.
DOI: 10.2337/db09-0530
发表时间: 2009-07
期刊: Diabetes
影响因子: 7.7
作者:
Saito M;Okamatsu-Ogura Y;Matsushita M;Watanabe K;Yoneshiro T;Nio-Kobayashi J;Iwanaga T;Miyagawa M;Kameya T;Nakada K;Kawai Y;Tsujisaki M
通讯作者: Tsujisaki M
DOI: 10.1210/jc.2013-1265
发表时间: 2013-09-01
影响因子: 5.8
作者:
Sacks, Harold S.;Fain, John N.;Symonds, Michael E.
通讯作者: Symonds, Michael E.
DOI: 10.1210/jc.2012-4213
发表时间: 2013-07-01
影响因子: 5.8
作者:
Chen, Kong Y.;Brychta, Robert J.;Celi, Francesco S.
通讯作者: Celi, Francesco S.
DOI: 10.1007/s00192-013-2042-x
发表时间: 2013-09
影响因子: 1.8
作者:
Chapple, Christopher R.;Dvorak, Vladimir;Radziszewski, Pjotr;Van Kerrebroeck, Philip;Wyndaele, Jean Jacques;Bosman, Brigitte;Boerrigter, Peter;Drogendijk, Ted;Ridder, Arwin;Van der Putten-Slob, Ingrid;Yamaguchi, Osamu
通讯作者: Yamaguchi, Osamu
DOI: 10.1016/s0140-6736(11)60812-x
发表时间: 2011-08-27
期刊: LANCET
影响因子: 168.9
作者:
Hall, Kevin D.;Sacks, Gary;Chandramohan, Dhruva;Chow, Carson C.;Wang, Y. Claire;Gortmaker, Steven L.;Swinburn, Boyd A.
通讯作者: Swinburn, Boyd A.